ArticleScientific reports2025

Preclinical approach of two novel tetrahydroquinoline derivatives targeting GPER and Bcl-2 for anti-glioblastoma therapy.

David Méndez-Luna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.